Is Vitamin B6 Sleep Meta-Analysis safe?

Updated July 2026

Quick Answer

Vitamin B6 Sleep Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Additionally, we performed a risk-of-bias analysis of the studies compatible with the RoB2 tool.

Key Takeaways

  • 01Additionally, we performed a risk-of-bias analysis of the studies compatible with the RoB2 tool. [Tortajada J (2026)]
  • 02Overall, the risk of bias was high, and the methodological quality was generally low. [Tortajada J (2026)]
  • 03Background Nutraceutical supplementation targeting mitochondrial function has been proposed as a beneficial therapeutic strategy to improve physical and mental health in psychiatric patients. [Tortajada J (2026)]
  • 04Aims To summarise the results of studies evaluating nutraceutical supplementation targeting mitochondrial function in patients with psychiatric disorders. [Tortajada J (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin B6 Sleep Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Additionally, we performed a risk-of-bias analysis of the studies compatible with the RoB2 tool. [Tortajada J (2026); evidence level 1] - Overall, the risk of bias was high, and the methodological quality was generally low. [Tortajada J (2026); evidence level 1] - Background Nutraceutical supplementation targeting mitochondrial function has been proposed as a beneficial therapeutic strategy to improve physical and mental health in psychiatric patients. [Tortajada J (2026); evidence level 1] - Aims To summarise the results of studies evaluating nutraceutical supplementation targeting mitochondrial function in patients with psychiatric disorders. [Tortajada J (2026); evidence level 1] - Concurrently, the number of individuals affected by dementia is anticipated to nearly triple by 2050, with associated treatment costs projected to reach US$2.8 trillion by 2030 []. [Liu Xing (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Clinical outcomes of mitochondrial-enhancing nutraceutical supplementation in psychiatric disorders: A systematic review.
  2. Nutritional supplements and cognition in healthy aging and mild cognitive impairment patients: a systematic review and network meta-analysis